Who is Robert Malone • 16 implied HN points • 13 Nov 24
- The Trump transition team is allowing people to suggest leaders for health policy roles, which could mean big changes in how health decisions are made.
- There are discussions about reorganizing the FDA and CDC to make them more effective, with ideas to reduce heavy regulations and focus on safety and innovation.
- Some people in the biopharmaceutical industry seem worried about a potential Trump presidency, as they are planning how to counter any major changes that could affect their power.